CompoAtlas

AYU RASAYANA (Paziņots 2014.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000384/2014
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
TRODO EUROPA, SIA
Manufacturer
Bliss Ayurveda Pvt. Ltd.
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
pieaugušajiem 1 tablete 2 reizes dienā
Published pack size
tablete pa 1000 mg
Published packaging
60 tabletes

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Kalcijsminerals ; Kalcijs ; 36 ; mgCalciumVitamin or mineral
Cinksminerals ; Cinks ; 15 ; mgZincVitamin or mineral
Dzelzsminerals ; Dzelzs ; 11 ; mgFerVitamin or mineral
Varšminerals ; Varš ; 1800 ; μgCuivreVitamin or mineral
Emblikas augļapvalka pulveris 2 tabletēsplants ; Emblikas augļapvalka pulveris 2 tabletēs ; Phyllanthus emblica L. ; 640 ; mgphyllanthus emblicaPlant
Sparģeļu saknes pulveris 2 tabl.plants ; Sparģeļu saknes pulveris 2 tabl. ; Asparagus racemosus ; 320 ; mgasparagus racemosusPlant
Kudzu saknes pulveris 2 tabl.plants ; Kudzu saknes pulveris 2 tabl. ; Pueraria lobata ; 300 ; mgNot recognisedRole not identified
Terminālijas, cebulu, augļapvalka pulveris 2 tabl.plants ; Terminālijas, cebulu, augļapvalka pulveris 2 tabl. ; Terminalia chebula Retz. ; 160 ; mgterminalia chebulaPlant
Vīnogu sēkliņu ekstrakts 1:10 (2 tabl.)plants ; Vīnogu sēkliņu ekstrakts 1:10 (2 tabl.) ; Vitis euvitis ; 120 ; mgNot recognisedRole not identified
Granātābolu augļu ekstrakts 1:10 (2 tabl.)plants ; Granātābolu augļu ekstrakts 1:10 (2 tabl.) ; Punica granatum ; 120 ; mgpunica granatumPlant
Garā pipara augļu pulveris 2 tabl.plants ; Garā pipara augļu pulveris 2 tabl. ; Piper longum L. ; 120 ; mgpiper longumPlant
Mikrokristāliskā celuloze (E 460)otherIngredients ; Mikrokristāliskā celuloze (E 460)Listed as food additive E 460(i) (EU Union list)Role not identified
Akācijas sveķi (E 414)otherIngredients ; Akācijas sveķi (E 414)Listed as food additive E 414 (EU Union list)Role not identified
Magnija stearāts (E470b)otherIngredients ; Magnija stearāts (E470b)Listed as food additive E 470b (EU Union list)Role not identified
Dzelzs oksīdi (E 172)otherIngredients ; Dzelzs oksīdi (E 172)Listed as food additive E 172 (EU Union list)Role not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Indija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Emblikas augļapvalka pulveris 2 tabletēs
    Read the warning, when it applies and the studies cited

    Amla - Phyllanthus Emblica

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Applies to products providing more than 3 grams of amla, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Condition of application: Amlapitta, Digestive tonic.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Laxative.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).

    Sources cited by Health Canada (3)
    • CPhA 2002: Repchinsky C, editor-in-chief. Patient Self-Care: Helping Patients Make Therapeutic Choices. 1st edition. Ottawa (ON): Canadian Pharmacists Association; 2002.
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
    • Pray WS. Non-Prescription Product Therapeutics. 2nd edition. New York (NY): Lippincott Williams & Wilkins; 2006.

    Contraindications

    Condition of application: Laxative.

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Known adverse reactions

    Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.

    When using this product you may experience a laxative effect.

    Health Canada monograph dated 28 March 2025

  • Granātābolu augļu ekstrakts 1:10 (2 tabl.)
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “AYU RASAYANA (Paziņots 2014.)”, https://compoatlas.com/en/supplements/latvia/4462-ayu-rasayana-pazinots-2014, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line